Healthcare Providers and Services
Company Overview of Ameritox, Ltd.
Ameritox, Ltd., doing business as Ameritox Limited Partnership, develops pain medication monitoring solutions for pain management. It offers laboratory services and practice management tools; Rx GuardianCD, a urine drug monitoring solution; Rx Guardian INSIGHT Report, which provides physicians with a view of their chronic pain patient’s medication monitoring results; and Rx Guardian results report that provides information available on patients’ pain medication use in easy-to-read format. The company also provides clinical staff training and support, results interpretation and support, and online services; Risperdal, a method to help assess medication adherence in behavioral health patients ...
300 East Lombard Street
Baltimore, MD 21202
Founded in 1996
Key Executives for Ameritox, Ltd.
Chief Financial Officer and Senior Vice President
Chief Laboratory Officer and Senior Vice President
Senior Vice President of Managed Care
Compensation as of Fiscal Year 2015.
Ameritox, Ltd. Key Developments
Ingenuity Health Expands Reference Database to Help Assess Medication Adherence in Those with Serious Mental Illness
Jul 14 15
Ingenuity Health, a service of Ameritox Ltd. expanded its comprehensive reference database that helps clinicians assess medication adherence among patients with Serious Mental Illness. Ingenuity Health has developed a method to help assess adherence in patients prescribed the antipsychotic drug lurasidone, marketed under the brand name Latuda®. The reference database provides behavioral health clinicians help in addressing the ongoing problem of medication non-adherence in those with SMI.
Ameritox's Ingenuity Health Introduces Method to Help Assess Medication Adherence in Patients Prescribed Risperdal
Oct 21 14
Ameritox announced that it has launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug risperidone (tradename, Risperdal). This new method marks a critical step toward establishing a comprehensive reference database for commonly prescribed antipsychotic medications, providing behavioral health clinicians help in addressing the acute problem of medication non-adherence in those with serious mental illness. The company’s Ingenuity Health service conducted research that allows it to provide additional information about whether a patient may be taking risperidone in accordance with his or her prescribed treatment plan. By comparing normalized urine drug results against the results of patients clinically assessed as adherent, behavioral health centers and medical professionals will have more information as they manage and treat patients prescribed risperidone. Risperidone now joins Abilify. In addition, Ingenuity Health offers detection tests for other drugs commonly prescribed to treat schizophrenia and bipolar disorder, including Clozaril, Geodon, Haldol, Invega, Zyprexa and Latuda.
Ameritox Appoints Thomas Smith as Chief Medical Officer
Oct 17 14
Ameritox announced the appointment of Thomas Smith, M.D., as Chief Medical Officer. In this role, Smith will lead a field-based team offering scientific resources for healthcare providers, patients and managed care plans. Smith has held leadership positions at a variety of healthcare companies that have provided him with experiences that will benefit both the pain and behavioral health sides of Ameritox's business. He most recently served as CMO for Mallinckrodt Pharmaceuticals, where he helped the company serve millions of patients around the world with effective and safe medications while helping to quickly grow the company's market capitalization from $2 billion to $8 billion.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|